Research updates from Luvaminos
Subscribe for catalog updates, new research compounds, and quality documentation releases.
For researchers and labs. No spam — unsubscribe anytime.
Research updates from Luvaminos
Subscribe for catalog updates, new research compounds, and quality documentation releases.
For researchers and labs. No spam — unsubscribe anytime.
Research Category
29 compounds in the peptide analogs category, each documented with third-party testing and a Certificate of Analysis. For research use only.
A C20-acylated 39-residue synthetic peptide characterized in cryo-EM structural studies of class B GPCR complexes.
View research referenceA 31-residue C18-acylated synthetic peptide analogue characterized by cryo-EM in complex with a class B GPCR.
View research referenceA 39-residue acylated synthetic peptide characterized in receptor-binding and cryo-EM structural studies of class B GPCR complexes.
View research referenceA synthetic 16-residue cyclic peptide corresponding to the C-terminal domain of human growth hormone, characterized by NMR conformational analysis and bioanalytical structure studies.
View research referenceA mitochondrial-encoded peptide investigated in cellular energy, signaling, and muscle biology research.
View research referenceA small-molecule NNMT inhibitor studied across adipocyte, skeletal-muscle, and cancer-stroma preclinical models.
View research referenceA two-component synthetic peptide preparation pairing a tetrasubstituted 29-residue GRF(1-29) analog with a five-residue amidated pentapeptide, used in comparative preclinical research.
View research referenceA tetrasubstituted 29-residue synthetic peptide corresponding to the N-terminal GRF(1-29) sequence, bearing a C-terminal albumin-binding side chain.
View research referenceA synthetic pentapeptide with non-coded residues and a C-terminal amide, characterized in receptor-binding and structure-activity studies.
View research referenceA 44-residue synthetic peptide carrying an N-terminal trans-3-hexenoyl group, studied at a class B GPCR.
View research referenceA synthetic six-residue peptide bearing a non-canonical D-2-methyltryptophan substitution and a C-terminal amide.
View research referenceA synthetic, C-terminally amidated hexapeptide built from non-natural D-amino acids and a 2-naphthylalanine residue, characterized in structural and receptor-binding studies of a class A G protein-coupled receptor.
View research referenceA synthetic, C-terminally amidated hexapeptide incorporating two D-amino-acid substitutions, studied as a tool compound in class A GPCR structural pharmacology.
View research referenceA synthetic cyclic heptapeptide (cyclic lactam, 7 residues) studied as a conformationally constrained reference ligand in class A GPCR binding, structure-activity chemistry, and structural-biology research.
View research referenceA 29-residue synthetic peptide corresponding to the N-terminal fragment of a 44-residue hypothalamic peptide, carrying four stabilizing residue substitutions and a C-terminal amide.
View research referenceA two-component preparation pairing a 29-residue amidated GRF(1-29) analog with a synthetic hexapeptide.
View research referenceAn albumin-binding 30-residue synthetic peptide corresponding to a tetrasubstituted GRF(1-29) sequence, studied in class B GPCR structural pharmacology and albumin-conjugation chemistry.
View research referenceA PEGylated IGF-1 splice-variant peptide studied in preclinical cellular and skeletal-muscle research models.
View research referenceA synthetic 29-residue C-terminally amidated peptide corresponding to the N-terminal fragment of a 44-residue hypothalamic peptide.
View research referenceA synthetic 26-residue peptidomimetic conjugate of a cysteine-flanked homing nonapeptide and a D-amino acid amphipathic heptapeptide repeat domain.
View research referenceA purine nucleoside analogue studied as a pharmacological AMPK-pathway probe in cell biology and preclinical metabolic research models.
View research referenceA 39-residue acylated synthetic peptide characterized in cryo-EM structural studies of class B GPCR complexes.
View research referenceA research peptide blend of a long-acting acylated peptide analog and the pentapeptide ipamorelin.
View research referenceA two-component synthetic peptide blend pairing a 29-residue amidated fragment analog with a 5-residue pentapeptide, both characterized in GPCR structural-biology studies.
View research referenceA synthetic small-molecule acylhydrazone studied as a chemical probe in nuclear-receptor and mitochondrial-metabolism research.
View research referenceA 29-residue acylated synthetic peptide characterized in cell-based receptor-pharmacology and structural research.
View research referenceA four-component research blend of three short synthetic peptides and a 24-residue E-peptide fragment corresponding to a splice variant of the IGF-1 gene, characterized by sequence, molecular formula, and structural class.
View research referenceA disulfide-cyclized 16-residue synthetic peptide corresponding to the C-terminal sequence of a 191-residue parent protein, examined in NMR conformational studies and isolated-tissue enzyme assays.
View research referenceA combined metabolic-research preparation pairing a mitochondrial-derived peptide with a small-molecule NNMT inhibitor.
View research referenceThese products are intended for research purposes only and are not for human consumption. Not FDA approved. Not intended to diagnose, treat, cure, or prevent any disease. For educational and research purposes only; not medical advice.